Scinovex
article Open AccessTop 10% cited

Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

BMC Cancer · 2011 · Vol. 11(1) · pp. 130–130
Gali SoriaMaya Ofri-ShahakIlana HaasNeora Yaal‐HahoshenLeonor Leider–TrejoTal Leibovich-RivkinPolina WeitzenfeldTsipi MeshelEsther ShabtaiMordechai GutmanAdit Ben‐Baruch

Abstract

Our findings suggest that the coordinated expression of CCL2 & CCL5 and TNFα & IL-1β may be important for disease course, and that TNFα & IL-1β may promote disease relapse. Further in vitro and in vivo studies are needed for determination of the joint powers of the four factors in breast cancer, as well as analyses of their combined targeting in breast cancer.

Chemokine receptors and signalingCancer Cells and MetastasisImmunotherapy and Immune ResponsesCCL5ChemokineBreast cancerMedicineEpithelial–mesenchymal transitionCCL2Tumor necrosis factor alphaCancer researchMetastasisOncology

MeSH terms

AdultBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingCell AdhesionCell MovementFemaleFlow CytometryHumansImmunohistochemistryMiddle AgedNeoplasm Recurrence, LocalTumor Necrosis Factor-alphaCarcinoma, Ductal, BreastMicroscopy, ConfocalInflammation Mediators

Funding

  • Federico and Elvia Faggin Foundation
  • Israel Science Foundation
Citations
280
FWCI
9.01
field-weighted impact
References
87
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition · Scinovex